Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 11/2017

02.08.2017 | Original Article – Cancer Research

Polymorphisms of GSTM1, GSTT1, GSTP1 genes and chromosomal aberrations in lung cancer patients

verfasst von: Varvara I. Minina, Olga A. Soboleva, Andrey N. Glushkov, Elena N. Voronina, Ekaterina A. Sokolova, Marina L. Bakanova, Yana A. Savchenko, Anastasia V. Ryzhkova, Ruslan A. Titov, Vladimir G. Druzhinin, Maxim Yu. Sinitsky, Maxim A. Asanov

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To study the potential links between genetic polymorphisms in the GSTT1, GSTM1, GSTP1 genes and the frequency of chromosomal aberrations (CAs) in lung cancer patients and healthy residents in Russian Federation.

Methods

200 cells in well-spread metaphase with 46 chromosomes were examined for 353 newly diagnosed lung cancer patients (males) who received medical treatment in the Kemerovo Regional Oncology Center (Kemerovo, Russian Federation), and 300 healthy males from Kemerovo, Russian Federation. The polymorphisms of the GSTM1 del and GSTT1 del genes were analysed by multiplex PCR. Genotyping of the polymorphic variants in the GSTP1 (A313G, T341C) gene was performed using Real-time PCR with competing TaqMan probes complementary to the polymorphic DNA sites. The data analysis was performed using software STATISTICA 8.0 (StatSoft Inc., USA).

Results

We discovered that a GSTM1 del polymorphism increases the frequency of chromosomal damage in smoking patients with lung cancer, a general group of lung cancer patients, donors with non-small cell lung cancer and patients in the latest stages of the malignant process. The synergetic effects of occupational exposure and the malignant process can induce some modifications in the cytogenetic status in lung cancer patients harbouring the GSTM1 del polymorphism.

Conclusions

CAs in peripheral blood lymphocytes can be used as biomarkers of the early biological effects of exposure to genotoxic carcinogens and may predict future cancer incidence in several epidemiologic studies. Genetic changes in genes encoding phase II detoxification enzymes are linked to decreases in the metabolic detoxification of environmentally derived genotoxic carcinogens.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Ada A, Demiroglu C, Yilmazer M et al (2013) Cytogenetic damage in Turkish coke oven workers exposed to polycyclic aromatic hydrocarbons: association with CYP1A1, CYP1B1, EPHX1, GSTM1, GSTT1, and GSTP1 gene polymorphisms. Arh Hig Rada Toksikol 64(3):359–369PubMed Ada A, Demiroglu C, Yilmazer M et al (2013) Cytogenetic damage in Turkish coke oven workers exposed to polycyclic aromatic hydrocarbons: association with CYP1A1, CYP1B1, EPHX1, GSTM1, GSTT1, and GSTP1 gene polymorphisms. Arh Hig Rada Toksikol 64(3):359–369PubMed
Zurück zum Zitat Anantharaman D, Samant TA, Sen S, Mahimkar MB (2011) Polymorphisms in tobacco metabolism and DNA repair genes modulate oral precancer and cancer risk. Oral Oncol 47:866–872CrossRefPubMed Anantharaman D, Samant TA, Sen S, Mahimkar MB (2011) Polymorphisms in tobacco metabolism and DNA repair genes modulate oral precancer and cancer risk. Oral Oncol 47:866–872CrossRefPubMed
Zurück zum Zitat Benhamou S, Lee WJ, Alexandrie AK et al (2002) Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 23:1343–1350CrossRefPubMed Benhamou S, Lee WJ, Alexandrie AK et al (2002) Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 23:1343–1350CrossRefPubMed
Zurück zum Zitat Boffetta P, van der Hel O, Norppa H et al (2007) Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe. Am J Epidemiol 165:36–43CrossRefPubMed Boffetta P, van der Hel O, Norppa H et al (2007) Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe. Am J Epidemiol 165:36–43CrossRefPubMed
Zurück zum Zitat Bonassi S, Ceppi M, Fontana V, Merlo F (1994) Multiple regression analysis of cytogenetic human data. Mutat Res 313:69–80CrossRefPubMed Bonassi S, Ceppi M, Fontana V, Merlo F (1994) Multiple regression analysis of cytogenetic human data. Mutat Res 313:69–80CrossRefPubMed
Zurück zum Zitat Bonassi S, Norppa H, Ceppi M et al (2008) Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22,358 subjects in 11 countries. Carcinogenesis 29:1178–1183CrossRefPubMedPubMedCentral Bonassi S, Norppa H, Ceppi M et al (2008) Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22,358 subjects in 11 countries. Carcinogenesis 29:1178–1183CrossRefPubMedPubMedCentral
Zurück zum Zitat Brogger A, Hagmar L, Hansteen IL et al (1990) An inter-Nordic prospective study on cytogenetic endpoints and cancer risk. Nordic Study Group on the Health Risk of Chromosome Damage. Cancer Genet Cytogenet 45:85–92CrossRefPubMed Brogger A, Hagmar L, Hansteen IL et al (1990) An inter-Nordic prospective study on cytogenetic endpoints and cancer risk. Nordic Study Group on the Health Risk of Chromosome Damage. Cancer Genet Cytogenet 45:85–92CrossRefPubMed
Zurück zum Zitat Cajas-Salazar N, Sierra-Torres CH, Salama S et al (2003) Combined effect of MPO, GSTM1 and GSTT1 polymorphisms on chromosome aberrations and lung cancer risk. Int J Hyg Environ Health 206:473–483CrossRefPubMed Cajas-Salazar N, Sierra-Torres CH, Salama S et al (2003) Combined effect of MPO, GSTM1 and GSTT1 polymorphisms on chromosome aberrations and lung cancer risk. Int J Hyg Environ Health 206:473–483CrossRefPubMed
Zurück zum Zitat Druzhinin VG (2003) Quantitative characteristics of the frequency of chromosomal aberrations in a group of residents of a large western Siberian industrial region. Russ J Genet 39:1161–1167CrossRef Druzhinin VG (2003) Quantitative characteristics of the frequency of chromosomal aberrations in a group of residents of a large western Siberian industrial region. Russ J Genet 39:1161–1167CrossRef
Zurück zum Zitat Druzhinin V, Bakanova M, Fucic A, Golovina T, Savchenko Y, Sinitsky M, Volobaev V (2016) Lymphocytes with multiple chromosomal damages in a large cohort of West Siberia residents: results of long-term monitoring. Mutat Res 784–785:1–7CrossRefPubMed Druzhinin V, Bakanova M, Fucic A, Golovina T, Savchenko Y, Sinitsky M, Volobaev V (2016) Lymphocytes with multiple chromosomal damages in a large cohort of West Siberia residents: results of long-term monitoring. Mutat Res 784–785:1–7CrossRefPubMed
Zurück zum Zitat Dusinska M, Staruchova M, Horska A, Smolkova B, Collins A, Bonassi S, Volkovova K (2012) Are glutathione S transferases involved in DNA damage signalling? Interactions with DNA damage and repair revealed from molecular epidemiology studies. Mutat Res 736:130–137CrossRefPubMed Dusinska M, Staruchova M, Horska A, Smolkova B, Collins A, Bonassi S, Volkovova K (2012) Are glutathione S transferases involved in DNA damage signalling? Interactions with DNA damage and repair revealed from molecular epidemiology studies. Mutat Res 736:130–137CrossRefPubMed
Zurück zum Zitat Garte S, Gaspari L, Alexandrie AK et al (2001) Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 10:1239–1248PubMed Garte S, Gaspari L, Alexandrie AK et al (2001) Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 10:1239–1248PubMed
Zurück zum Zitat Goldstraw P (2013) New staging system: how does it affect our practice? J Clin Oncol 31:984–991CrossRefPubMed Goldstraw P (2013) New staging system: how does it affect our practice? J Clin Oncol 31:984–991CrossRefPubMed
Zurück zum Zitat Hagmar L, Stromberg U, Bonassi S et al (2004) Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts. Cancer Res 64:2258–2263CrossRefPubMed Hagmar L, Stromberg U, Bonassi S et al (2004) Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts. Cancer Res 64:2258–2263CrossRefPubMed
Zurück zum Zitat Hayes JD, Strange RC (2000) Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61:154–166CrossRefPubMed Hayes JD, Strange RC (2000) Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61:154–166CrossRefPubMed
Zurück zum Zitat Hemminki K, Musak L, Vymetalkova V et al (2014) Cyclin D1 splice site variant triggers chromosomal aberrations in healthy humans. Leukemia 28:721–722CrossRefPubMed Hemminki K, Musak L, Vymetalkova V et al (2014) Cyclin D1 splice site variant triggers chromosomal aberrations in healthy humans. Leukemia 28:721–722CrossRefPubMed
Zurück zum Zitat Hemminki K, Frank C, Försti A et al (2015) Metabolic gene variants associated with chromosomal aberrations in healthy humans. Genes Chromosomes Cancer 54:260–266CrossRefPubMed Hemminki K, Frank C, Försti A et al (2015) Metabolic gene variants associated with chromosomal aberrations in healthy humans. Genes Chromosomes Cancer 54:260–266CrossRefPubMed
Zurück zum Zitat Hersh CP, DeMeo DL, Reilly JJ, Silverman EK (2007) Xenobiotic metabolizing enzyme gene polymorphisms predict response to lung volume reduction surgery. Respir Res 8:59CrossRefPubMedPubMedCentral Hersh CP, DeMeo DL, Reilly JJ, Silverman EK (2007) Xenobiotic metabolizing enzyme gene polymorphisms predict response to lung volume reduction surgery. Respir Res 8:59CrossRefPubMedPubMedCentral
Zurück zum Zitat Hoyos-Giraldo LS, Escobar-Hoyos LF, Reyes-Carvajal I et al (2013) The effect of genetic admixture in an association study: genetic polymorphisms and chromosome aberrations in a Colombian population exposed to organic solvents. Ann Hum Genet 77:308–320CrossRefPubMed Hoyos-Giraldo LS, Escobar-Hoyos LF, Reyes-Carvajal I et al (2013) The effect of genetic admixture in an association study: genetic polymorphisms and chromosome aberrations in a Colombian population exposed to organic solvents. Ann Hum Genet 77:308–320CrossRefPubMed
Zurück zum Zitat Kadioglu E, Kocabas NA, Demircigil GC et al (2012) Assessment of individual susceptibility to baseline DNA and cytogenetic damage in a healthy Turkish population: evaluation with lifestyle factors. Genet Test Mol Biomarkers 16:1157–1164CrossRefPubMedPubMedCentral Kadioglu E, Kocabas NA, Demircigil GC et al (2012) Assessment of individual susceptibility to baseline DNA and cytogenetic damage in a healthy Turkish population: evaluation with lifestyle factors. Genet Test Mol Biomarkers 16:1157–1164CrossRefPubMedPubMedCentral
Zurück zum Zitat Knudsen LE, Norppa H, Gamborg MO et al (1999) Chromosomal aberrations in humans induced by urban air pollution: influence of DNA repair and polymorphisms of glutathione S-transferase M1 and N-acetyltransferase 2. Cancer Epidemiol Biomark Prev 8:303–310 Knudsen LE, Norppa H, Gamborg MO et al (1999) Chromosomal aberrations in humans induced by urban air pollution: influence of DNA repair and polymorphisms of glutathione S-transferase M1 and N-acetyltransferase 2. Cancer Epidemiol Biomark Prev 8:303–310
Zurück zum Zitat Kumar A, Yadav A, Giri SK, Dev K, Gautam SK, Gupta R, Aggarwal N (2011) Effect of genetic polymorphism of GSTM1 and GSTT1 genotypes on cytogenetic biomarkers among coaltar workers. Environ Toxicol Pharmacol 32:128–135CrossRefPubMed Kumar A, Yadav A, Giri SK, Dev K, Gautam SK, Gupta R, Aggarwal N (2011) Effect of genetic polymorphism of GSTM1 and GSTT1 genotypes on cytogenetic biomarkers among coaltar workers. Environ Toxicol Pharmacol 32:128–135CrossRefPubMed
Zurück zum Zitat Landi S (2000) Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 463:247–283CrossRefPubMed Landi S (2000) Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 463:247–283CrossRefPubMed
Zurück zum Zitat Lee SA, Fowke JH, Lu W et al (2008) Cruciferous vegetables, the GSTP1 Ile105Val genetic polymorphism, and breast cancer risk. Am J Clin Nutr 87:753–760PubMed Lee SA, Fowke JH, Lu W et al (2008) Cruciferous vegetables, the GSTP1 Ile105Val genetic polymorphism, and breast cancer risk. Am J Clin Nutr 87:753–760PubMed
Zurück zum Zitat MacIntyre EA, Brauer M, Melén E et al (2014) GSTP1 and TNF gene variants and associations between air pollution and incident childhood asthma: the traffic, asthma and genetics (TAG) study. Environ Health Perspect 122:418–424PubMedPubMedCentral MacIntyre EA, Brauer M, Melén E et al (2014) GSTP1 and TNF gene variants and associations between air pollution and incident childhood asthma: the traffic, asthma and genetics (TAG) study. Environ Health Perspect 122:418–424PubMedPubMedCentral
Zurück zum Zitat Mielzynska-Svach D, Blaszczyk E, Butkiewicz D, Durzynska J, Rydzanicz M (2013) Influence of genetic polymorphisms on biomarkers of exposure and effects in children living in Upper Silesia. Mutagenesis 28:591–599CrossRefPubMed Mielzynska-Svach D, Blaszczyk E, Butkiewicz D, Durzynska J, Rydzanicz M (2013) Influence of genetic polymorphisms on biomarkers of exposure and effects in children living in Upper Silesia. Mutagenesis 28:591–599CrossRefPubMed
Zurück zum Zitat Minina VI, Savchenko IA, Bakanova ML et al (2011) Contribution of genetic polymorphism to the formation of individual genome sensitivity in workers engaged in heat and power industry. Gig Sanit 5:30–32 Minina VI, Savchenko IA, Bakanova ML et al (2011) Contribution of genetic polymorphism to the formation of individual genome sensitivity in workers engaged in heat and power industry. Gig Sanit 5:30–32
Zurück zum Zitat Mušák L, Halašová E, Matáková T et al (2009) Comparison of chromosomal aberrations frequency and polymorphism of GSTs genes in workers occupationally exposed to cytostatics or anaesthetics. Interdiscip Toxicol 2:190–194PubMedPubMedCentral Mušák L, Halašová E, Matáková T et al (2009) Comparison of chromosomal aberrations frequency and polymorphism of GSTs genes in workers occupationally exposed to cytostatics or anaesthetics. Interdiscip Toxicol 2:190–194PubMedPubMedCentral
Zurück zum Zitat Norppa H (1997) Cytogenetic markers of susceptibility: influence of polymorphic carcinogenme- tabolizing enzymes. Env Health Pers 105:829–835CrossRef Norppa H (1997) Cytogenetic markers of susceptibility: influence of polymorphic carcinogenme- tabolizing enzymes. Env Health Pers 105:829–835CrossRef
Zurück zum Zitat Oskina NA, Ermolenko NA, Boyarskih UA et al (2014) Associations between SNPs within antioxidant genes and the risk of prostate cancer in the Siberian region of Russia. Pathol Oncol Res 20:635–640CrossRefPubMed Oskina NA, Ermolenko NA, Boyarskih UA et al (2014) Associations between SNPs within antioxidant genes and the risk of prostate cancer in the Siberian region of Russia. Pathol Oncol Res 20:635–640CrossRefPubMed
Zurück zum Zitat Palmer CN, Doney AS, Lee SP, Murrie I, Ismail T, Macgregor DF, Mukhopadhyay S (2006) Glutathione S-transferase M1 and P1 genotype, passive smoking, and peak expiratory flow in asthma. Pediatrics 118:710–716CrossRefPubMed Palmer CN, Doney AS, Lee SP, Murrie I, Ismail T, Macgregor DF, Mukhopadhyay S (2006) Glutathione S-transferase M1 and P1 genotype, passive smoking, and peak expiratory flow in asthma. Pediatrics 118:710–716CrossRefPubMed
Zurück zum Zitat Pan C, Zhu G, Yan Z, Zhou Y, Liu Z (2014) Glutathione S-transferase T1 and M1 polymorphisms are associated with lung cancer risk in a gender-specific manner. Oncol Res Treat 37:164–169CrossRefPubMed Pan C, Zhu G, Yan Z, Zhou Y, Liu Z (2014) Glutathione S-transferase T1 and M1 polymorphisms are associated with lung cancer risk in a gender-specific manner. Oncol Res Treat 37:164–169CrossRefPubMed
Zurück zum Zitat Pliarchopoulou K, Voutsinas G, Papaxoinis G et al (2012) Correlation of CYP1A1, GSTP1 and GSTM1 gene polymorphisms and lung cancer risk among smokers. Oncol Lett 3:1301–1306PubMedPubMedCentral Pliarchopoulou K, Voutsinas G, Papaxoinis G et al (2012) Correlation of CYP1A1, GSTP1 and GSTM1 gene polymorphisms and lung cancer risk among smokers. Oncol Lett 3:1301–1306PubMedPubMedCentral
Zurück zum Zitat Rebbeck TR (1997) Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 6:733–743PubMed Rebbeck TR (1997) Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 6:733–743PubMed
Zurück zum Zitat Rossi AM, Hansteen IL, Skjelbred CF et al (2009) Association between frequency of chromosomal aberrations and cancer risk is not influenced by genetic polymorphisms in GSTM1 and GSTT1. Environ Health Perspect 117:203–238CrossRefPubMed Rossi AM, Hansteen IL, Skjelbred CF et al (2009) Association between frequency of chromosomal aberrations and cancer risk is not influenced by genetic polymorphisms in GSTM1 and GSTT1. Environ Health Perspect 117:203–238CrossRefPubMed
Zurück zum Zitat Rossner P, Boffetta P, Ceppi M et al (2005) Chromosomal aberration in lymphocytes of healthy subjects and risk of cancer. Environ Health Perspect 113:517–520CrossRefPubMedPubMedCentral Rossner P, Boffetta P, Ceppi M et al (2005) Chromosomal aberration in lymphocytes of healthy subjects and risk of cancer. Environ Health Perspect 113:517–520CrossRefPubMedPubMedCentral
Zurück zum Zitat Sambrook J, Fritsch E, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor Sambrook J, Fritsch E, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
Zurück zum Zitat Santovito A, Cervella P, Delpero M (2015) Baseline frequency of chromosomal aberrations and sister chromatid exchanges in peripheral blood lymphocytes of healthy individuals living in Turin (North-Western Italy): assessment of the effects of age, sex and GSTs gene polymorphisms on the levels of genomic damage. Ann Hum Biol 24:1–10 Santovito A, Cervella P, Delpero M (2015) Baseline frequency of chromosomal aberrations and sister chromatid exchanges in peripheral blood lymphocytes of healthy individuals living in Turin (North-Western Italy): assessment of the effects of age, sex and GSTs gene polymorphisms on the levels of genomic damage. Ann Hum Biol 24:1–10
Zurück zum Zitat Scarpato R, Hirvonen A, Migliore L, Falck G, Norppa H (1997) Influence of GSTM1 and GSTT1 polymorphisms on the frequency of chromosome aberrations in lymphocytes of smokers and pesticide-exposed greenhouse workers. Mutat Res 389:227–235CrossRefPubMed Scarpato R, Hirvonen A, Migliore L, Falck G, Norppa H (1997) Influence of GSTM1 and GSTT1 polymorphisms on the frequency of chromosome aberrations in lymphocytes of smokers and pesticide-exposed greenhouse workers. Mutat Res 389:227–235CrossRefPubMed
Zurück zum Zitat Sharma N, Singh A, Singh N, Behera D, Sharma S (2015) Genetic polymorphisms in GSTM1, GSTT1 and GSTP1 genes and risk of lung cancer in a North Indian population. Cancer Epidemiol 39:947–955CrossRefPubMed Sharma N, Singh A, Singh N, Behera D, Sharma S (2015) Genetic polymorphisms in GSTM1, GSTT1 and GSTP1 genes and risk of lung cancer in a North Indian population. Cancer Epidemiol 39:947–955CrossRefPubMed
Zurück zum Zitat Skjelbred C, Svendsen M, Haugan V et al (2011) Influence of GSTM1, GSTT1, GSTP1, NAT1, NAT2, EPHX1, MTR and MTHFR polymorphism on chromosomal aberration frequencies in human lymphocytes. Carcinogenesis 32:399–405CrossRefPubMed Skjelbred C, Svendsen M, Haugan V et al (2011) Influence of GSTM1, GSTT1, GSTP1, NAT1, NAT2, EPHX1, MTR and MTHFR polymorphism on chromosomal aberration frequencies in human lymphocytes. Carcinogenesis 32:399–405CrossRefPubMed
Zurück zum Zitat Spitz MR, Wei Q, Dong Q, Amos CI, Wu X (2003) Genetic susceptibility to lung cancer: the role of DNAdamage and repair. Cancer Epidemiol Biomarkers Prev 12:689–698PubMed Spitz MR, Wei Q, Dong Q, Amos CI, Wu X (2003) Genetic susceptibility to lung cancer: the role of DNAdamage and repair. Cancer Epidemiol Biomarkers Prev 12:689–698PubMed
Zurück zum Zitat Sun KH, Chang KH, Clawson S et al (2011) Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity. J Neurochem 118:902–914CrossRefPubMed Sun KH, Chang KH, Clawson S et al (2011) Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity. J Neurochem 118:902–914CrossRefPubMed
Zurück zum Zitat Tamer L, Calikoğlu M, Ates NA et al (2004) Glutathione-S-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1) as increased risk factors for asthma. Respirology 9:493–498CrossRefPubMed Tamer L, Calikoğlu M, Ates NA et al (2004) Glutathione-S-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1) as increased risk factors for asthma. Respirology 9:493–498CrossRefPubMed
Zurück zum Zitat Vodenkova S, Polivkova Z, Musak L et al (2015) Structural chromosomal aberrations as potential risk markers in incident cancer patients. Mutagenesis 30:557–563CrossRefPubMed Vodenkova S, Polivkova Z, Musak L et al (2015) Structural chromosomal aberrations as potential risk markers in incident cancer patients. Mutagenesis 30:557–563CrossRefPubMed
Zurück zum Zitat Vodicka P, Kumar R, Stetina R et al (2004) Markers of individual susceptibility and DNA repair rate in workers exposed to xenobiotics in a tire plant. Environ Mol Mutagen 44:283–292CrossRefPubMed Vodicka P, Kumar R, Stetina R et al (2004) Markers of individual susceptibility and DNA repair rate in workers exposed to xenobiotics in a tire plant. Environ Mol Mutagen 44:283–292CrossRefPubMed
Zurück zum Zitat Vodicka P, Polivkova Z, Sytarova S et al (2010) Chromosomal damage in peripheral blood lymphocytes of newly diagnosed cancer patients and healthy controls. Carcinogenesis 31:1238–1241CrossRefPubMed Vodicka P, Polivkova Z, Sytarova S et al (2010) Chromosomal damage in peripheral blood lymphocytes of newly diagnosed cancer patients and healthy controls. Carcinogenesis 31:1238–1241CrossRefPubMed
Zurück zum Zitat Zhang H, Wu X, Xiao Y, Chen M, Li Z, Wei X, Tang K (2014) Genetic polymorphisms of glutathione S-transferase M1 and T1, and evaluation of oxidative stress in patients with non-small cell lung cancer. Eur J Med Res 19:67CrossRefPubMedPubMedCentral Zhang H, Wu X, Xiao Y, Chen M, Li Z, Wei X, Tang K (2014) Genetic polymorphisms of glutathione S-transferase M1 and T1, and evaluation of oxidative stress in patients with non-small cell lung cancer. Eur J Med Res 19:67CrossRefPubMedPubMedCentral
Metadaten
Titel
Polymorphisms of GSTM1, GSTT1, GSTP1 genes and chromosomal aberrations in lung cancer patients
verfasst von
Varvara I. Minina
Olga A. Soboleva
Andrey N. Glushkov
Elena N. Voronina
Ekaterina A. Sokolova
Marina L. Bakanova
Yana A. Savchenko
Anastasia V. Ryzhkova
Ruslan A. Titov
Vladimir G. Druzhinin
Maxim Yu. Sinitsky
Maxim A. Asanov
Publikationsdatum
02.08.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 11/2017
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-017-2486-3

Weitere Artikel der Ausgabe 11/2017

Journal of Cancer Research and Clinical Oncology 11/2017 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.